Novan Inc (NOVN) - Financial and Strategic SWOT Analysis Review

Novan Inc (NOVN) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH355644FSA
  • |
  • Pages: 45
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Novan Inc (NOVN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Novan Inc (Novan) is a clinical-stage pharmaceutical company that develops nitric oxide therapies for the treatment of dermatological and oncovirus-mediated diseases. The company's pipeline products are being developed for the treatment of acne vulgaris; genital warts; for onychomycosis and for treatment of psoriasis and atopic dermatitis. Novan uses its proprietary technology Nitricil, to customize macromolecular delivery of nitric oxide and store gaseous species which result in nitric oxide-releasing new chemical entities for healthcare applications. The company's products find application in the treatment of dermatology disorders. It works in collaboration with academic institutions, public and private companies and other universities. Novan is headquartered in Morrisville, North Carolina, the US.

Novan Inc Key Recent Developments

Apr 12,2018: Novan Advances Organization and Strengthens Leadership Team

Feb 21,2018: Dr. Eugene Sun Appointed to Novan Board of Directors

Jan 19,2018: Novan Announces Resignation Of William L. Hodges As Interim Chief Financial Office

Sep 26,2017: Machelle Sanders Appointed to Novan Board of Directors

Sep 26,2017: Novan adds another former RTP biotech exec to its board

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Novan Inc-Key Facts 5

Novan Inc-Key Employees 6

Novan Inc-Key Employee Biographies 7

Novan Inc-Major Products and Services 8

Novan Inc-History 9

Novan Inc-Company Statement 10

Novan Inc-Locations And Subsidiaries 12

Head Office 12

Section 2-Company Analysis 13

Company Overview 13

Novan Inc-Business Description 14

R&D Overview 14

Novan Inc-SWOT Analysis 15

SWOT Analysis-Overview 15

Novan Inc-Strengths 15

Novan Inc-Weaknesses 16

Novan Inc-Opportunities 17

Novan Inc-Threats 18

Novan Inc-Key Competitors 19

Section 3-Company Financial Ratios 20

Financial Ratios-Capital Market Ratios 20

Financial Ratios-Annual Ratios 21

Performance Chart 23

Financial Performance 23

Financial Ratios-Interim Ratios 24

Financial Ratios-Ratio Charts 25

Section 4-Company's Lifesciences Financial Deals and Alliances 26

Novan Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

Novan Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27

Novan Inc, Recent Deals Summary 28

Section 5-Company's Recent Developments 29

Apr 12, 2018: Novan Advances Organization and Strengthens Leadership Team 29

Feb 21, 2018: Dr. Eugene Sun Appointed to Novan Board of Directors 30

Sep 26, 2017: Machelle Sanders Appointed to Novan Board of Directors 31

Aug 16, 2017: Novan Appoints Paula Brown Stafford, Chief Development Officer, to Board of Directors 32

Jun 05, 2017: Novan Announces Leadership Adjustments and Business Update 33

May 12, 2017: Novan Reports First Quarter 2017 Financial Results 35

Apr 04, 2017: Novan Welcomes Key Opinion Leaders to New Advisory Council 36

Mar 22, 2017: Novan Reshapes Executive Management Team 37

Mar 20, 2017: Novan Reports Fourth Quarter and Full Year 2016 Financial Results 39

Section 6-Appendix 41

Methodology 41

Ratio Definitions 41

About GlobalData 45

Contact Us 45

Disclaimer 45

List of Figures

Novan Inc, Performance Chart (2013-2017) 23

Novan Inc, Ratio Charts 25

Novan Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

Novan Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 27

List of Tables

Novan Inc, Key Facts 5

Novan Inc, Key Employees 6

Novan Inc, Key Employee Biographies 7

Novan Inc, Major Products and Services 8

Novan Inc, History 9

Novan Inc, Key Competitors 19

Novan Inc, Ratios based on current share price 20

Novan Inc, Annual Ratios 21

Novan Inc, Annual Ratios (Cont...1) 22

Novan Inc, Interim Ratios 24

Novan Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

Novan Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27

Novan Inc, Recent Deals Summary 28

Currency Codes 41

Capital Market Ratios 41

Equity Ratios 42

Profitability Ratios 42

Cost Ratios 43

Liquidity Ratios 43

Leverage Ratios 44

Efficiency Ratios 44

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Viamet Pharmaceuticals Inc

Melinta Therapeutics Inc

Helix BioMedix Inc

Aviragen Therapeutics Inc

AnaptysBio Inc

Novan Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8920
Site License
USD 250 INR 17840
Corporate User License
USD 375 INR 26760

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com